MICHAEL POWELL - 15 Jun 2022 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Director
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Michael F. Powell
Issuer symbol
GRTX
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
16 Jun 2022, 16:05:44 UTC
Previous filing
31 May 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 15 Jun 2022 Common Stock 20,000 $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of June 15, 2023 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Remarks:

Exhibit 24 - Power of Attorney